Lv5
1110 积分 2022-04-11 加入
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
18天前
已完结
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer
1个月前
已完结
Delayed drug reactions: The next frontier in drug allergy?
1个月前
已关闭
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
1个月前
已完结
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
1个月前
已完结
Bimagrumab: an investigational human monoclonal antibody against activin type II receptors for treating obesity
3个月前
已完结
[Phase Ⅲ, multicenter, randomized comparative study of LY01005 and Zoladex® for patients with premenopausal breast cancer]
4个月前
已完结
[The 2023 Chinese menopause symptom management and menopausal hormone therapy guidelines]
4个月前
已完结
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
5个月前
已关闭
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
8个月前
已关闭
皖公网安备34019202002308
